| View |
|
DR-XY34643
|
Cotrimoxazole
|
Trimostat
|
200 mg/40 mg per 5 mL
|
Powder for Suspension
|
Antibacterial (Sulfonamide)
|
Flamingo Pharmaceuticals Ltd.
|
India
|
Renewal
|
28 March 2023
|
11 June 2028
|
| View |
|
DR-XY34644
|
Seroquel XR
|
Quetiapine (As Fumarate)
|
50 mg
|
Extended-Release Tablet
|
-
|
AstraZeneca Pharmaceuticals LP
|
U.S.A.
|
-
|
19 June 2020
|
15 September 2025
|
| View |
|
DR-XY34646
|
Cefotaxime (As Sodium)
|
Haxim
|
1 g
|
Powder For Injection
|
Antibacterial (Cephalosporins)
|
Harbin Pharmaceutical Group Co., Ltd. General Pharm. Factory
|
China
|
Automatic Renewal
|
12 July 2023
|
25 June 2028
|
| View |
|
DR-XY34653
|
Doxofylline
|
Puroxan
|
100 mg/5mL
|
Syrup
|
Bronchodilator
|
M&H Manufacturing Co., Ltd.
|
Thailand
|
Renewal
|
29 May 2024
|
16 June 2029
|
| View |
|
DR-XY34666
|
Simvastatin
|
Lochol
|
40 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Siam Bheasach Co. Ltd
|
Thailand
|
Automatic Renewal
|
04 May 2023
|
26 June 2028
|
| View |
|
DR-XY34668
|
Sildenafil (As Citrate)
|
Sildegra
|
50mg
|
Film-Coated Tablet
|
PDE5 Inhibitor
|
Intas Pharmaceuticals Limited
|
India
|
Automatic Renewal
|
15 June 2023
|
26 June 2028
|
| View |
|
DR-XY3467
|
Sodium Chloride
|
None
|
2.5 mEq / mL
|
Solution for I.V. Infusion
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
11 December 2020
|
05 February 2026
|
| View |
|
DR-XY34671
|
Aceclofenac
|
Clanza S
|
100mg
|
Softgel Capsule
|
Non-Steroidal Anti-Inflammatory Drugs (NSAID)
|
Korea United Pharm. Inc.
|
Korea
|
Renewal
|
18 August 2021
|
26 March 2027
|
| View |
|
DR-XY34691
|
Isotonic Electrolyte Solution (I.V.)
|
Sterofundin ISO
|
per 500 mL
Sodium Chloride 3.4 g
Potassium Chloride 0.15 g
Calcium Chloride Dihydrate 0.185 g
Magnesium Chloride Hexahydrate 0.1 g
Sodium Acetate Trihydrate 1.635 g
Malic Acid 0.335 g
per 1000 mL
Sodium Chloride 6.80 g
Potassium Chloride 0.30 g
Calcium Chloride Dihydrate 0.37 g
Magnesium Chloride Hexahydrate 0.20 g
Sodium Acetate Trihydrate 3.27 g
Malic Acid 0.67 g
|
I.V. Solution
|
Electrolyte Replenisher
|
B. Braun Melsungen AG
|
Germany
|
Automatic Renewal
|
29 September 2022
|
13 September 2027
|
| View |
|
DR-XY34709
|
Levetiracetam
|
Keppra
|
100 mg/mL
|
Oral Solution
|
Anticonvulsant
|
Next Pharma SAS - Limay
|
France
|
Automatic Renewal
|
14 July 2023
|
10 July 2028
|
| View |
|
DR-XY34718
|
Thiamine (Vitamins B1) + Pyridoxine Hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
Neuroxel 500
|
500mg/250mg/1mg
|
Tablet
|
Vitamin
|
Sydenham Laboratories Inc
|
Philippines
|
Automatic Renewal
|
03 July 2023
|
14 July 2028
|
| View |
|
DR-XY347215
|
Ibuprofen
|
Medbufen
|
100 mg/5 mL
|
Suspension
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
13 May 2023
|
17 July 2028
|
| View |
|
DR-XY34725
|
Ibuprofen
|
Medbufen
|
100 mg/5 mL
|
Suspension
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
13 May 2023
|
17 July 2028
|
| View |
|
DR-XY34740
|
Folic Acid
|
Folart
|
5 mg/5 mL
|
Syrup
|
Vitamin
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
04 August 2024
|
05 December 2029
|
| View |
|
DR-XY34741
|
Folic Acid
|
Folart
|
2.5 mg/mL
|
Syrup (Oral Drops)
|
Anti-anaemia (Hematinic)
|
Lloyd Laboratories, Inc
|
Philippines
|
Renewal
|
27 March 2023
|
25 July 2028
|
| View |
|
DR-XY34746
|
Sodium Alginate+ Sodium Bicarbonate + Calcium Carbonate
|
Gaviscon
|
500 mg/267 mg/160 mg per 10 mL
|
Oral Suspension
|
Antacid
|
Reckitt Benckiser Healthcare (UK) Limited
|
United Kingdom
|
Automatic Renewal
|
11 February 2023
|
25 July 2028
|
| View |
|
DR-XY34755
|
Erythromycin (as ethylsuccinate)
|
Erycar
|
100mg/2.5mL
|
Granules For Suspension (Oral Drops)
|
Antibacterial (Macrolide)
|
Ace Pharmaceuticals, Inc.
|
Philippines
|
Renewal
|
04 August 2023
|
30 July 2028
|
| View |
|
DR-XY34756
|
Cephradine
|
Zolicef
|
500 mg
|
Powder For Injection
|
Antibacterial (Cephalosporin)
|
Harbin Pharmaceutical Group Co., Ltd. General Pharm. Factory
|
China
|
Automatic Renewal
|
28 June 2023
|
30 July 2028
|
| View |
|
DR-XY34761
|
Perindopril Erbumine
|
Perigard-2
|
2 mg
|
Tablet
|
Angiotensin Converting Enzyme (ACE) Inhibitor
|
Glenmark Pharmaceuticals Ltd.
|
India
|
Automatic Renewal
|
06 March 2023
|
30 July 2028
|
| View |
|
DR-XY34774
|
Iron Sucrose
|
Ferrofer
|
20 mg/mL
|
Solution For Injection (Iv)
|
-
|
Nanjing Hencer Pharmaceutical Co., Ltd.
|
China
|
-
|
18 August 2020
|
06 August 2025
|